Metastatic colorectal cancer Trials in Valencia, Spain
Conditions / Metastatic colorectal cancer / Valencia, Spain
Clinical trials for Metastatic colorectal cancer investigate a range of treatment strategies and patient populations.
29 total trials for this combination
Showing top 10 of 29 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04322539 | A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer | COMPLETED | PHASE3 |
| NCT04793958 | Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) | ACTIVE_NOT_RECRUITING | — |
| NCT04793958 | Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) | ACTIVE_NOT_RECRUITING | — |
| NCT04929223 | A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC) | RECRUITING | — |
| NCT06252649 | Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation | RECRUITING | — |
| NCT01767857 | A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer | TERMINATED | PHASE3 |
| NCT04657068 | A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT06252649 | Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation | RECRUITING | — |
| NCT04008030 | A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06792695 | A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer | RECRUITING | PHASE2 |